Gomes JE da C, Santos PFP dos, Alvarenga VM. CARDIOVASCULAR BENEFITS OF CANAGLIFLOZIN USE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: AN INTEGRATIVE REVIEW. REASE [Internet]. 2025 Oct. 29 [cited 2026 Oct. 1];11(10):5153-65. Available from: https://periodicorease.pro.br/rease/article/view/21802